Verve Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $6.7M | 595k | 11.23 |
| 2025-03-31 | $1.6M | 342k | 4.57 |
| 2024-12-31 | $1.2M | 214k | 5.64 |
| 2024-09-30 | $4.2M | 870k | 4.84 |
| 2024-06-30 | $2.8M | 570k | 4.88 |
| 2024-03-31 | $16M | 1.2M | 13.28 |
| 2023-12-31 | $7.4M | 532k | 13.94 |
| 2023-09-30 | $3.8M | 289k | 13.26 |
| 2023-06-30 | $13M | 708k | 18.75 |
| 2023-03-31 | $6.3M | 435k | 14.42 |
| 2022-12-31 | $3.1M | 158k | 19.35 |
| 2022-06-30 | $19M | 1.2M | 15.28 |
| 2022-03-31 | $23M | 1.0M | 22.82 |
| 2021-12-31 | $21M | 569k | 36.87 |
| 2021-09-30 | $31M | 666k | 45.78 |
| 2021-06-30 | $49M | 830k | 58.71 |